These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 24014920

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. DRESS syndrome associated with raltegravir.
    Zhang KS, Modi GM, Hsu S.
    Dermatol Online J; 2011 Aug 15; 17(8):14. PubMed ID: 21906494
    [Abstract] [Full Text] [Related]

  • 7. Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus.
    Knudtson E, Para M, Boswell H, Fan-Havard P.
    Obstet Gynecol; 2003 May 15; 101(5 Pt 2):1094-7. PubMed ID: 12738113
    [Abstract] [Full Text] [Related]

  • 8. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
    Fernando SL.
    Australas J Dermatol; 2014 Feb 15; 55(1):15-23. PubMed ID: 23866082
    [Abstract] [Full Text] [Related]

  • 9. [Cutaneous, hepatic and hematologic manifestations due to nevirapine: DRESS syndrome?].
    Sissoko D, Ajana F, de la Tribonnière X, Baclet V, Mouton Y.
    Presse Med; 2014 Feb 15; 29(19):1041-2. PubMed ID: 10874910
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Optimal treatment of nevirapine-associated hepatotoxicity remains uncertain.
    Bundow D, Rosoff L, Aboulafia DM.
    AIDS Read; 2001 Nov 15; 11(11):577-80. PubMed ID: 11789021
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Desensitization to Nevirapine.
    TreatmentUpdate; 1999 Nov 01; 11(8):5. PubMed ID: 11367044
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate.
    Cacoub P, Descamps V, Meyer O, Speirs C, Belissa-Mathiot P, Musette P.
    Osteoporos Int; 2013 May 01; 24(5):1751-7. PubMed ID: 23361875
    [Abstract] [Full Text] [Related]

  • 17. Drug neosensitization during anticonvulsant hypersensitivity syndrome.
    Gaig P, García-Ortega P, Baltasar M, Bartra J.
    J Investig Allergol Clin Immunol; 2006 May 01; 16(5):321-6. PubMed ID: 17039674
    [Abstract] [Full Text] [Related]

  • 18. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome).
    Tas S, Simonart T.
    Acta Clin Belg; 1999 Aug 01; 54(4):197-200. PubMed ID: 10544509
    [Abstract] [Full Text] [Related]

  • 19. Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis.
    Shaughnessy KK, Bouchard SM, Mohr MR, Herre JM, Salkey KS.
    J Am Acad Dermatol; 2010 Feb 01; 62(2):315-8. PubMed ID: 19665822
    [Abstract] [Full Text] [Related]

  • 20. [Drug rash with eosinophilia and systemic symptoms (DRESS) attributed to the oral skin-care supplement Imedeen].
    van Leeuwen JF, van der Hooft CS, Vos LE, Bekkenk MW, van Zuuren EJ, Stricker BH.
    Ned Tijdschr Geneeskd; 2005 Jun 11; 149(24):1353-6. PubMed ID: 16008041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.